The Development and Evaluation of an "E-Visit" Program for the Management of Acne
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00417456|
Recruitment Status : Completed
First Posted : January 1, 2007
Last Update Posted : March 16, 2012
The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:
- That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.
- That providers and patients will be satisfied with this model.
- That mean wait times for new and return visits will be reduced through the "E-Visit" model.
- That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.
|Condition or disease||Intervention/treatment|
|Acne Vulgaris||Other: Evisit Other: Office visit|
Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.
Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.
Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:
Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.
Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.
At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||151 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||The Development and Evaluation of an "E-Visit" Program for the Management of Acne|
|Study Start Date :||October 2005|
|Primary Completion Date :||December 2007|
|Study Completion Date :||December 2007|
Active Comparator: 1
Other: Office visit
Conventional office-based care
Asynchronous,remote care delivery via a secure web platform
Other Name: RelayHealth platform
- Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment [ Time Frame: 6 months ]
- Subject satisfaction [ Time Frame: 6 months ]
- Physician satisfaction [ Time Frame: 6 months ]
- Timing of visits [ Time Frame: ongoing ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00417456
|United States, Massachusetts|
|MGH Dermatology Associates|
|Boston, Massachusetts, United States, 02114|
|Brigham and Women's Hospital Department of Dermatology|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Joseph C. Kvedar, M.D.||Massachusetts General Hospital|